In the second part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explains ...

A panel of industry leaders emphasize the importance of early engagement with payers, real-world evidence, and value-based ...

In the first part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses ...

In the final part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, describes what meaningful ...

Leading stakeholders in the industry react to how evolving US policies, payer demands, and vertical integration are reshaping ...

When automatically moved from a zero-dollar silver plan to one that requires a premium due to plan turnover, do lower-income health insurance marketplace enrollees lose or switch coverage?

The new system meets the increasing demand for faster, more precise processes that enhance quality while boosting efficiency ...

Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization. A Pharmaceutical Executive article explores how specialty pharmacy programs can significantly improve outcomes ...

GLP-1 Drugs may be Linked to Elevated Risk of Serious Eye Disease, Study Finds. A new observational study finds that people with diabetes taking GLP-1 drugs have a low but doubled risk of developing ...

A cross-sectional study investigates whether becoming eligible for Medicare at age 65 is linked to changes in healthcare use ...

In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where ...

Key Takeaways. Tariffs could spike drug costs: Proposed 25% tariffs on pharmaceuticals may raise US drug prices by up to 12.9% and cost the industry an estimated $51 billion annually.; Supply chain ...